We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-24.42%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$137M
AUM Growth
+$14.4M
Cap. Flow
+$30.3M
Cap. Flow %
22.19%
Top 10 Hldgs %
90.6%
Holding
116
New
26
Increased
16
Reduced
32
Closed
31

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.59%
2 Healthcare 7.31%
3 Consumer Discretionary 1.12%
4 Communication Services 0.83%
5 Energy 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINGW icon
51
Cingulate Inc Warrants
CINGW
$93.4K 0.07%
565,769
-1,859
-0.3% -$262
BJDX icon
52
Bluejay Diagnostics
BJDX
$869K
$91.9K 0.07%
+13
New +$122K
NRXP icon
53
NRX Pharmaceuticals
NRXP
$144M
$84.5K 0.06%
32,500
-37,473
-54% -$125K
FRZA
54
DELISTED
Forza X1, Inc. Common Stock
FRZA
$83.8K 0.06%
102,787
-290,624
-74% -$312K
TRKA
55
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$82.5K 0.06%
74,999
+20,413
+37% +$35.7K
BFRGW icon
56
Bullfrog AI Holdings Warrants
BFRGW
$82.2K 0.06%
145,090
-14,845
-9% -$8.16K
ANY icon
57
CALL
Sphere 3D
ANY
$24.9M
$75.1K 0.06%
57
WLDSW icon
58
Wearable Devices Ltd Warrant
WLDSW
$170K
$70.8K 0.05%
934
-665
-42% -$66.4K
BCLI
59
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$61K 0.04%
+203
New +$4.62K
VINC
60
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$57.9K 0.04%
2,868
-2,287
-44% -$44.4K
IFBD icon
61
Infobird
IFBD
$8.1M
$53.1K 0.04%
3,128
+2,978
+1,985% +$251K
BNBX
62
DELISTED
BNB PLUS CORP
BNBX
$47.1K 0.03%
+3
New +$63.2K
APDNW
63
PUT
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$47.1K 0.03%
+389
New +$47.1K
SMFL
64
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$44.9K 0.03%
2,595
-1,363
-34% -$44.3K
NCRA icon
65
Nocera
NCRA
$5.13M
$43.5K 0.03%
+951
New +$45.2K
LEXXW
66
DELISTED
Lexaria Bioscience Warrant
LEXXW
$42K 0.03%
209,979
-30,227
-13% -$7.23K
GMBLZ
67
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$37K 0.03%
4,629,529
CTRM icon
68
Castor Maritime
CTRM
$23.1M
$36K 0.03%
8,240
+51
+0.6% +$226
CTRM icon
69
PUT
Castor Maritime
CTRM
$23.1M
$36K 0.03%
82
BCLI
70
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$27.3K 0.02%
9,099
-75,426
-89% -$1.71M
CAN
71
CALL
Canaan Creative
CAN
$239M
$25.7K 0.02%
141
GWAV icon
72
Greenwave Technology Solutions
GWAV
$2.9M
$21.1K 0.02%
+2
New +$27.9K
GMVD
73
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$20.4K 0.02%
352,922
-337,412
-49% -$90K
NMTR
74
DELISTED
9 Meters Biopharma
NMTR
$20.1K 0.01%
1,672,627
+634,187
+61% +$298K
BRSHW
75
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$19.2K 0.01%
551,458
+15,351
+3% +$582

Similar funds

Sabby Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sabby Management held 116 positions worth $137M, up 12% from $122M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management deployed $30.3M of net new capital in Q3 2023, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 77% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was BRAINSTORM CELL THERAPUTC, an estimated $1.71M trimmed.

  • Sabby Management's largest Q3 2023 buy was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.
  • Sabby Management added most to Neptune Wellness Solutions Inc. Ordinary Shares in Q3 2023, an estimated $799K increase.
  • Sabby Management's biggest Q3 2023 reduction was BRAINSTORM CELL THERAPUTC, cutting an estimated $1.71M.
  • Sabby Management fully exited Sonnet BioTherapeutics in Q3 2023, selling an estimated $1.61M.
  • Sabby Management's ten largest holdings make up 91% of its $137M portfolio in Q3 2023.
  • Sabby Management opened 26 new positions and closed 31 in Q3 2023.
  • Sabby Management's portfolio value rose 12% quarter-over-quarter to $137M.

Based on Sabby Management's 13F filing for Q3 2023, filed 14 Nov 2023.